SGRYNASDAQHealthcare

Public company intelligence preview

SURGERY PARTNERS INC

43 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
43
0 filed in the last 30 days
Acquisition / disposition count
25/18
Buy / Sell
Unique insiders active in the last year
15
Current insider positions tracked
19
19 active, 0 exited

Insider compensation

Public aggregate: $2.4M average total compensation across covered insiders.

Governance movement

Public aggregate: 4 governance events in the last year.

Institutional ownership

Public aggregate: 180 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
44
Restricted-sale insiders, 1Y
9
Planned sale shares, 1Y
1.1M
Planned sale value, 1Y
$24.5M
Insiders covered
11
Latest year: 2025
Personnel changes, 1Y
3
Board appointments, 1Y
2
Board departures, 1Y
2

Market context

Basic quote context for the preview.

Price
$13.76
Market cap
$1.8B
Volume
5,276
EPS
$-0.28
Revenue
$810.9M
Employees
16.0K

Company note

Context before the data.

Company Overview

Surgery Partners Inc. is a healthcare services company focused on outpatient surgical care and related ancillary services, operating more than 200 locations across 30 states. Its portfolio includes ambulatory surgery centers, short-stay surgical hospitals, anesthesia, urgent care, and physician practices, with core specialties such as orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. The company’s model is built around lower-cost, scheduled procedures versus acute-care hospitals, and it relies heavily on physician partnerships, acquisitions, and de novo expansion to grow. Recent filings show solid revenue growth, supported by higher case volume and revenue per case, while the mix of private insurance and government payors remains a key business feature.

Executive Compensation Practices

For a company like Surgery Partners in the Healthcare sector and Medical Care Facilities industry, executive compensation is likely to be tied closely to revenue growth, same-facility performance, adjusted EBITDA, and cash flow generation. The filing summaries highlight metrics that matter most to management, including case volume, revenue per case, facility integration, margin discipline, and successful acquisition activity, which are all natural candidates for incentive targets. Because the business is capital-intensive and debt-sensitive, compensation structures may also emphasize liquidity, leverage management, and refinancing execution, especially given the company’s elevated interest expense and recent debt issuance. In this sector, executives are often rewarded for expanding physician relationships, improving payor mix, and maintaining regulatory and operational compliance while scaling the platform.

Insider Trading Considerations

Insider trading behavior at Surgery Partners may be influenced by fluctuations in procedure volumes, reimbursement trends, and payor mix, since these factors can quickly affect margins and valuation. Because the company depends heavily on private insurance and government reimbursement, insiders may be especially sensitive to policy changes, Medicaid/Medicare rate updates, or state supplemental payment programs that can alter profitability. Trading windows may also be shaped by periodic acquisition activity, divestitures, refinancing events, and earnings seasonality, since those events can move the stock materially in a business with meaningful leverage and margin sensitivity. In a regulated healthcare services business, insiders also need to navigate restrictions around material nonpublic information tied to transaction pipelines, reimbursement negotiations, and compliance matters such as anti-kickback and Stark Law exposure.

Unlock the full SGRY insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.